What Happened?
Shares of self defense company AXON (NASDAQ:AXON) fell 8.7% in the morning session after the company announced a proposed registered public offering of $1.0 billion of 0% convertible senior notes due September 15, 2031.
Per a company press release, the offering includes an option for underwriters to acquire up to an additional $150.0 million aggregate principal amount of notes solely to cover over-allotments. Axon stated that it plans to use proceeds from the debt offering for capped call transactions to reduce potential dilution, with remaining funds allocated for general corporate purposes. Additionally, the company reported entering into a second amendment to its credit agreement. Convertible note offerings frequently place downward pressure on share prices due to investor concerns over potential equity dilution upon conversion.
The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy Axon? Access our full analysis report here, it’s free.
What Is The Market Telling Us
Axon’s shares are extremely volatile and have had 42 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The biggest move we wrote about over the last year was 7 months ago when the stock gained 23.8% on the news that it reported strong fourth-quarter financial results that beat Wall Street's expectations and provided an upbeat outlook for the future. For the quarter, Axon's revenue reached $796.7 million, marking a 38.5% increase compared to the same period in the previous year and surpassing analysts' forecasts. The company's adjusted earnings per share came in at $2.15, which was significantly higher than the consensus estimate of $1.60. This strong performance and confident guidance appeared to drive positive investor sentiment.
Axon is down 21% since the beginning of the year, and at $445.40 per share, it is trading 42.7% below its 52-week high of $777.58 from September 2025. Despite the year-to-date decline, investors who bought $1,000 worth of Axon’s shares 5 years ago would now be looking at an investment worth $2,505.
ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.
AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.